ANK1 and histiocytic sarcoma: A previous Brazilian study identified ANK1 variants in only 10% of HS patients, suggesting that mutations inANK1 might not be as common in Brazil asdescribed for the Northern European population, where ANK1 mutations account for ~ 50% of HS cases [10, 14, 15].